2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1043253024 MD
Verify on CMS →

ALINA GAVRILA, MD

Endocrinology, Diabetes & Metabolism Physician in BOSTON, Massachusetts. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
818
Medicare Part D claims · 175 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
54%
generic claims · 46% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

ALINA GAVRILA, MD filed 818 Medicare Part D claims in 2023 as a Endocrinology, Diabetes & Metabolism Physician in BOSTON, Massachusetts, prescribing 54% generic.

818
Part D claims, 2023
54%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

ALINA GAVRILA, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

818 Top 27% higher than 73% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). This entry sits in this band. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

ALINA GAVRILA, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about ALINA GAVRILA, MD?

Quality data not reported

NPI registry status

Active

Issued 06/14/2006

NPI 1043253024

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

7,852 US NPIs in this specialty

Medicare Part D claims

818 69% vs specialty avg

2023 prescription claims

Specialty avg: 2,639

Specialty distribution in Massachusetts

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Massachusetts providers

Massachusetts providers

Endocrinology, Diabetes & Metabolism Physician share within Massachusetts

1. Endocrinology, Diabetes & Metabolism Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Endocrinology, Diabetes & Metabolism Physician share within Massachusetts

Specialty board-certification context

Estimated specialty board-certified rate — Endocrinology, Diabetes & Metabolism Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Endocrinology, Diabetes & Metabolism Physician ABMS/AOA estimate

Est. board-certified rate (Endocrinology, Diabetes & Metabolism Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Endocrinology, Diabetes & Metabolism Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ALINA GAVRILA, MD appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding MD credentials at 330 BROOKLINE AVE, BOSTON, MA, 02215, with a listed phone of (617) 667-9344. NPI 1043253024 was issued on 06/14/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GAVRILA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 818 prescription claims written by this provider, covering 175 Medicare beneficiaries and totaling roughly $123K in drug spend, split 46% brand-name and 54% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

330 BROOKLINE AVE
BOSTON, MA 02215

Provider Details

NPI 1043253024
Specialty Endocrinology, Diabetes & Metabolism Physician
Credentials MD
Gender Female
NPI Issued 06/14/2006

Hospital and facility affiliations

Facilities where ALINA GAVRILA, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

BETH ISRAEL DEACONESS MEDICAL CENTER INC
BOSTON, MA
HARVARD MEDICAL FACULTY PHYS AT BETH ISRAEL DEACONESS MED CTR INC
BOSTON, MA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

License & disciplinary context — Massachusetts BORIM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 — they are NOT specific to ALINA GAVRILA, MD. To verify ALINA GAVRILA, MD's current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

80
Total board actions, Massachusetts 2023
Across 78 cases
2.11
Actions per 1,000 licensees
Massachusetts statewide rate
probation
Most common action type
29 cases

BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

ALINA GAVRILA, MD — brand share 46.0%
Specialty average (est.)

46% brand-name claims vs 54% generic, on 818 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

818
Total Claims
$123K
Total Drug Cost
175
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,029
Total Day Supply
60,588
Brand vs Generic
46% brand / 54% generic
Brand Drug Cost
$93K
Generic Drug Cost
$28K

Patient Demographics

Average Patient Age
73.5 years
Avg HCC Risk Score
1.13
Gender Split
86% female / 14% male
Age Distribution
<65: 11, 65-74: 95, 75-84: 50, 85+: 19

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What ALINA GAVRILA, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Levothyroxine Sodium
233
Levoxyl
Levothyroxine Sodium
143
Synthroid
Levothyroxine Sodium
123
Alendronate Sodium
91
Methimazole
56
Prednisone
30
Cinacalcet Hcl
15
Hydrochlorothiazide
15
Testosterone
14
Hydrocortisone
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How ALINA GAVRILA, MD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

7,852
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider

ALINA GAVRILA, MD's 818 claims are below the specialty average of 2,639.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Massachusetts

Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as GAVRILA.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is ALINA GAVRILA, MD's specialty?
ALINA GAVRILA, MD specializes in Endocrinology, Diabetes & Metabolism Physician and practices in BOSTON, Massachusetts. Credentials: MD.
How much does ALINA GAVRILA, MD prescribe under Medicare Part D?
In 2023, ALINA GAVRILA, MD wrote 818 Medicare Part D claims totaling $123K in drug costs for 175 beneficiaries.
Where is ALINA GAVRILA, MD located?
ALINA GAVRILA, MD is located at 330 BROOKLINE AVE, BOSTON, MA, 02215. Phone: (617) 667-9344.
What is ALINA GAVRILA, MD's NPI number?
ALINA GAVRILA, MD's National Provider Identifier (NPI) is 1043253024, issued on 06/14/2006.
Does ALINA GAVRILA, MD prescribe more brand-name or generic drugs?
ALINA GAVRILA, MD's prescribing is 46% brand-name and 54% generic drugs by claim count, with $93K in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 7,852 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does ALINA GAVRILA, MD prescribe most often?
Based on 2023 Medicare Part D data, ALINA GAVRILA, MD's most frequently prescribed drugs include Levothyroxine Sodium, Levoxyl, Synthroid. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ALINA GAVRILA, MD accept Medicare?
ALINA GAVRILA, MD appears in CMS Medicare data with 818 Part D claims and 175 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ALINA GAVRILA, MD's credentials?
ALINA GAVRILA, MD's NPI is 1043253024 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology